Biomarin Pharmaceutical (BMRN)

Add to Watchlists
Create an Alert
120.92 -0.73  -0.60% NASDAQ Apr 17, 5:00PM BATS Real time Currency in USD
View Full Chart
BMRN Price Chart
View All Events

BMRN Events

Date Type Description
04/30/2015 16:30 EDT Misc Biomarin Pharmaceutical Inc First Quarter Earnings Conference Call in 2015
04/30/2015 Earnings Biomarin Pharmaceutical Inc First Quarter Earnings in 2015 Release
02/25/2015 16:30 EST Misc Biomarin Pharmaceutical Inc Fourth Quarter Earnings Conference Call in 2014
02/25/2015 Earnings Biomarin Pharmaceutical Inc Fourth Quarter Earnings in 2014 Release
12/10/2014 08:00 EST Misc Biomarin Pharmaceuticals' Analyst & Investor Day
10/23/2014 16:30 EDT Misc Q3 2014 BioMarin Pharmaceutical Inc. Earnings Conference Call
10/23/2014 Earnings Q3 2014 BioMarin Pharmaceutical Inc. Earnings Results
07/30/2014 16:30 EDT Misc Q2 2014 Biomarin Earnings Conference Call
07/30/2014 Earnings Q2 2014 Biomarin Earnings Results
05/01/2014 17:00 EDT Misc Q1 2014 Biomarin Earnings Conference Call
View All Performance Charts

BMRN Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Biomarin Pharmaceutical is up 97.03% over the last year vs S&P 500 Total Return up 14.04%, Biogen up 43.95%, and Celgene up 59.95%.

Get Quote for

PDF Report for BMRN

Download Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.

Download BMRN Pro Report PDF
Advertisement

Portfolio Strategies Featuring BMRN

Did Biomarin Pharmaceutical make it into our Portfolio Strategies?
Start your YCharts membership now to find out.

BMRN Profile

  • Sector: Healthcare
  • Industry: Biotechnology
  • Company Website: http://www.bmrn.com
  • IR Website: http://investors.bmrn.com/
  • HQ Country: United States
  • HQ State/Province: California
  • Incorporation Country: United States
  • Incorporation State/Province: Delaware
  • Est. Current Fiscal Quarter End: June 30, 2015
  • Est. Current Fiscal Year End: December 31, 2015
  • Last Fiscal Quarter End: December 31, 2014
  • Last Fiscal Year End: December 31, 2014
  • Next Earnings Release: April 30, 2015
  • NAICS: Pharmaceutical Preparation Manufacturing
  • NAICS Code: 325412
  • NAICS Industry: Pharmaceutical and Medicine Manufacturing
  • NAICS Sector: Manufacturing

Biomarin Pharmaceutical Inc develops and commercializes pharmaceuticals for serious diseases and medical conditions. Its product portfolio is comprised of five product candidates Naglazyme, Kuvan, Aldurazyme, VIMIZIM and Firdapse.

BMRN Excel Add-In Codes

  • Name: =YCI("BMRN","name")
  • Description: =YCI("BMRN","description")
  • Sector: =YCI("BMRN","sector")
  • Industry: =YCI("BMRN","industry")
  • Est. Current Fiscal Year End: =YCI("BMRN","fye")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

You've hit the 10 page limit on YCharts.

Experience the power of YCharts.
Start your Free 7-Day Trial.

Start My Free Trial No credit card required.

Already a subscriber? Sign in.

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}
Start your free 7-Day Trial.

{{root.upsell.info.button_text}} No credit card required.

Already a subscriber? Sign in.